Regarding polymorphisms in ACE2 gene itself, it is known that variants in this genetic locus promote pharmacogenetic modulation of ACE inhibitors response [41] and therefore they have now been under scrutiny as genetic susceptibility loci for COVID-19 outcomes [42]. Here, ACE is linked to COVID-19.